Inhibition of endotoxin-induced pro-inflammatory markers by water extracts of Onopordum cynarocephalum and Achillea damascena

Journal of Medicinal Plants Research

Volumn 3, Issue 9, 2009, Pages 686-696

  Talhouk, Rabih S ^a   Esseili, Malak A ^a   Kogan, Joanna ^a   Atallah, Marwan R ^a   Talhouk, Salma N ^a   Homaidan, Fadia R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Achillea damascene; Il 6, gelatinases; Inflammation; Mammary cells; NF B; Onopordum cynarocephalum

Indexed keywords

ACHILLEA DAMASCENA EXTRACT; ANTIINFLAMMATORY AGENT; BETA CASEIN; BIOLOGICAL MARKER; ENDOTOXIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; ONOPORDUM CYNAROCEPHALUM EXTRACT; PLANT EXTRACT; PROTEIN; UNCLASSIFIED DRUG;

ACHILLEA; ACHILLEA DAMASCENA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; ONOPORDUM; ONOPORDUM CYNAROCEPHALUM; PAW EDEMA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACHILLEA; ACHILLEA DAMASCENA; BOVINAE; ONOPORDUM CYNAROCEPHALUM; RATTUS;

EID: 73449122985     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ajuwon KM, Jacobi SK, Kuske JL, Spurlock ME (2004). Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286(3): 547-53.
2. Akeil M (1997). Al Ilaj bel Aashab; Beirut: Mouasaset Al Aalami lel Matbouaat. pp. 446-447.
3. An SJ, Pae HO, Oh GS, Choi BM, Jeong S, Jang SI, Oh H, Kwon TO, Song CE, Chung HT (2002). Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae). Int Immunopharmacol. 2(8): 1173-1181.
4. Bork PM, Schmitz ML, Kuhnt M, Escher C, Heinrich M (1997). Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor κB (NF-κB). FEBS Lett. 402: 85-95.
5. Calixto JB, Otuki MF, Santos AR (2003). Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med. 69(11): 973-83.
6. Cheng D, Shen Q, Nan F, Qian Z, Ye QZ (2003). Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening. Protein Expr Purif. 27(1): 63-74.
7. Cook-Mills JM, Deem TL (2005). Active participation of endothelial cells in inflammation. J. Leukoc. Biol. 77(4): 487-495.
8. Cragg GM, Newman DJ, Snader KM (1997). Natural products in drug discovery and development. J. Nat. Prod. 60: 52-60.
9. Doppler W, Geymayers S, Weirich HG (2000). Synergistic and antagonistic interactions of transcription factors in the regulation of milk protein gene expression. Mechanism of cross-talk between signaling pathways. Adv. Exp. Med. Biol. 480: 139-46.
10. Geymayer S, Doppler W (2000). Activation of NF-kappa B P50/P65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB J. 14(9): 1159-70.
11. Griesbeck-Zilch B, Meyer HH, Kühn CH, Schwerin M, Wellnitz O (2008). Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells. J. Dairy Sci. 91(6): 2215-24.
12. Günther J, Koczan D, Yang W, Nürnberg G, Repsilber D, Schuberth HJ, Park Z, Maqbool N, Molenaar A, Seyfert HM (2009). Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli. Vet. Res. 40(4): 31.
13. Hanemaaijer R, Koolwijk P, Le Clercq L, De Vree WJ, Van Hinsbergh VW (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J. 296: 803-809.
14. Harborne JB (1998). A guide to modern techniques of plant analysis. Phytochemical Methods. Chapman and Hall, 3rd Edition p. 302.
15. Heyen JR, Ye S, Finck BN, Johnson RW (2000). Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77(1): 138-47.
16. Ishii R, Horie M, Saito K, Arisawa M, Kitanaka S (2003). Inhibition of lipopolysaccharide-induced pro-inflammatory cytokine expression via suppression of nuclear factor-kappaB activation by Mallotus japonicus phloroglucinol derivatives. Biochem. Biophys. Acta. 1620(1-3): 108-118.
17. Kalari SK, Zhao Y, Spannhake EW, Berdyshev EV, Natarajan V (2009). Role of Acylglycerol Kinase in LPA-Induced IL-8 Secretion and Transactivation of Epidermal Growth Factor-Receptor in Human Bronchial Epithelial Cells. Am. J. Physiol. Lung Cell Mol. Physiol. 296: 328-36.
18. Libermann TA, Baltimore D (1990). Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10(5): 2327-2334.
19. Mannello F, Canesi L, Gazzanelli G, Gallo G (2001). Biochemical properties of metalloproteinases from the hemolymph of the mussel Mytilus galloprovincialis Lam. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 128(3): 507-515.
20. Matrisian LM (1992). The Matrix-degrading Metalloproteinases. Bioessays 14(7): 455-463.
21. Matu EN, Van-Staden J (2003). Antibacterial and anti-inflammatory activities of some plants used for medicinal purposes in Kenya. J. Ethnopharmacol. 87(1): 35-41.
22. McClenahan D, Krueger R, Lee HY, Thomas C, Kehrli ME Jr, Czuprynski C (2006). Interleukin-8 expression by mammary gland endothelial and epithelial cells following experimental mastitis infection with E. coli. Comp Immunol. Microbiol. Infect. Dis. (2-3): 127-37.
23. Merfort I (2003). Arnica: new insights on the molecular mode of action of a traditional medicinal plant. Forsch Komplementarmed Klass Naturheilkd 10(1): 45-8.
24. Mkarzel K (1997). Al Tadawi Bel-nabatat Al Tabiaaya; Beirut: Dar El Hadara pp. 19-20.
25. O'Connor CM, FitzGerald MX (1994). Matrix metalloproteases and lung disease. Thorax 49(6): 602-9.
26. O'Donnell SA (1999). Yarrow: the new cold stopper. Prevention 51: 44.
27. Phillipson JD (2003). 50 years of medicinal plant research - every progress in methodology is a progress in science. Planta Med. 69(6): 491-5.
28. Rezaeipoor R, Saeidnia S, Kamalinejad M (1999). Immunosuppressive activity of Achillea talagonica on humoral immune responses in experimental animals. J. Ethnopharmacol. 65(3): 273-6.
29. Ruwaiha A (1981). Altadawi Bil Aa'shab; Beirut : Dar Alkalam pp. 42-43.
30. Safieh-Garabedian B, Mouneimne GM, El-Jouni W, Khattar M, Talhouk R (2004). The effect of endotoxin on functional parameters of mammary CID-9 cells. Reproduction 127(3): 397-406.
31. Saliba NA, Dakdouki S, Homeidan F, Kogan J, Bouhadir K, Talhouk S, Talhouk R (2008). Bio-guided fractionation, Isolation and structure identification of an anti-inflammatory guaianolids from Centaurea ainetensis. Pharm. Biol. (in press).
32. Sasu S, Beasley D (2000). Essential roles of IkappaB kinases alpha and beta in serum- and IL-1-induced human VSMC proliferation. Am. J. Physiol. Heart Circ. Physiol. 278(6): 1823-31.
33. Shian SG, Kao YR, Wu FY, Wu CW (2003). Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol. Pharmacol. 64(5): 1076-84.
34. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB (2004). Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol. Lung Cell Mol. Physiol. 287(1): 143-52.
35. Talhouk RS, Elble RC, Bassam R, Daher M, Sfeir A, Mosleh LA, El-Khoury H, Hamoui S, Pauli BU, El-Sabban ME (2005). Developmental expression patterns and regulation of connexins in the mouse mammary gland: expression of connexin30 in lactogenesis. Cell Tissue Res. 319(1): 49-59.
36. Talhouk RS, El-Jouni W, Baalbaki R, Gali-Muhtasib H, Kogan J, Talhouk SN (2008). Anti-inflammatory bio-activities in water extract of Centaurea ainetensis. J. Med. Plants Res. 2(2): 024-033.
37. Talhouk RS, Hajjar L, Abou-Gergi R, Simaa'n CJ, Mouneimne G, Saade' NE, Safieh-Garabedian B (2000). Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain. Pain. 84(2-3): 397-405.
38. Talhouk RS, Saade' NE, Mouneimne G, Masaad CA, Safieh-Garabedian B (2004). Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. Prog Neuropsychopharmacol Biol. Psychiatry. 28(4): 625-31.
39. Tsai SH, Lin-Shiau SY, Lin JK (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126: 673-80.
40. U.N. agency report 2004 "WHO Issues Guidelines for Herbal Medicines" http://www.nlm.nih.gov/medlineplus/news.
41. Vona-Davis L, Zhu X, Yu AK, McFadden DW (2003). Modulation of interleukin-6 in cardiac myoblasts during endotoxemia. J. Surg. Res. 112(1): 91-96.
42. Yang J, Kennelly JJ, Baracos VE (2000). The activity of transcription factor Stat5 responds to prolactin, growth hormone, and IGF-I in rat and bovine mammary explant culture. J. Anim. Sci. 78(12): 3114-25.
43. Zimmerman M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16: 109-110.